申请人:Hoffmann-La Roche Inc.
公开号:US03989681A1
公开(公告)日:1976-11-02
Novel 1,4-benzodiazepin-2-ones of the formula ##SPC1## Wherein R.sub.1 is selected from the group consisting of hydrogen, lower alkyl, cycloalkyl-lower alkyl, hydroxylower alkyl, lower alkoxy-lower alkyl and di-lower alkylamino-lower alkyl; R.sub.2 signifies hydrogen or lower alkyl; R.sub.3 signifies hydrogen or halogen; R.sub.4 signifies lower alkyl And the pharmaceutically acceptable acid addition salts thereof, are disclosed together with processes for preparing these compounds and novel intermediates used in these processes. These 7-azoxy substituted-1,4-benzodiazepin-2-ones are useful as muscle relaxant, anti-convulsant and sedative agents.
公开了一种式为##SPC1##的新型1,4-苯二氮杂环己酮,其中R.sub.1选自氢、较低烷基、环烷基-较低烷基、羟基较低烷基、较低烷氧基-较低烷基和二较低烷氨基-较低烷基组成的基团;R.sub.2表示氢或较低烷基;R.sub.3表示氢或卤素;R.sub.4表示较低烷基及其药学上可接受的酸盐,以及用于制备这些化合物的过程和用于这些过程的新型中间体。这些7-偶氮基取代的1,4-苯二氮杂环己酮可用作肌肉松弛剂、抗惊厥剂和镇静剂。